Website Header with Language Selector and Dropdowns
Image

Pancuronium Bromide


Catalog Number: CL-PCRN-01
CAS No.: 15500-66-0
Mol.F: C35H60N2O4 : 2(Br)
Mol.W: 572.9 : 2(79.9)
Inv. Status: Custom Synthesis

Chemical Name: 1,1'-[3a,17?-Bis(acetyloxy)-5a-androstane-2?,16?-diyl]bis(1-methylpiperidinium) dibromide (as per EP) ; Piperidinium, 1,1'-[(2?,3a,5a,16?,17?)-3,17-bis(acetyl oxy)androstane-2,16-diyl]bis[1-methyl]-, dibromide.

Country of Origin: India

Product Category: Pancuronium Bromide Impurities


Pancuronium Bromide is identified by CAS No. 15500-66-0 and is chemically known as 1,1'-[3a,17?-Bis(acetyloxy)-5a-androstane-2?,16?-diyl]bis(1-methylpiperidinium) dibromide (as per EP) ; Piperidinium, 1,1'-[(2?,3a,5a,16?,17?)-3,17-bis(acetyl oxy)androstane-2,16-diyl]bis[1-methyl]-, dibromide.

Pancuronium Bromide is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Pancuronium Bromide.

Page Keywords: Buy Pancuronium Bromide | Purchase Pancuronium Bromide | Pancuronium Bromide suppliers | Pancuronium Bromide manufacturers | Pancuronium Bromide price | Pancuronium Bromide Importer | Pancuronium Bromide Exporter

Enquiry Now

Personal Details

Product Details

Related Products

CAT No: CL-PCRN-02
CAS No: 27115-86-2
Mol Wt: 530.8 : 2(79.9)
Mol F: C33H58N2O3 : 2(Br)
Inv. Status: Custom Synthesis
CAT No: CL-PCRN-03
CAS No: 41261-71-6
Mol Wt: 530.8 : 2(79.9)
Mol F: C33H58N2O3 : 2(Br)
Inv. Status: Custom Synthesis
CAT No: CL-PCRN-04
CAS No: 15500-65-9
Mol Wt: 488.8 : 2(79.9)
Mol F: C31H56N2O2 : 2(Br)
Inv. Status: Custom Synthesis
CAT No: CL-PCRN-05
CAS No: 50700-72-6
Mol Wt: 557.8 : 79.9
Mol F: C34H57N2O4 : Br
Inv. Status: Custom Synthesis
CAT No: CL-PCRN-06
CAS No: 13529-31-2
Mol Wt: 542.8
Mol F: C33H54N2O4
Inv. Status: Custom Synthesis
Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.